W3C home > Mailing lists > Public > public-semweb-lifesci@w3.org > September 2011

REMINDER - NCBO Webinar: Michael Kellen, Sage Bionetworks, Sep. 7

From: Trish Whetzel <plwhetzel@gmail.com>
Date: Tue, 6 Sep 2011 08:08:16 -0700
Message-ID: <CAE4f=njqtf+gG8WSZV3KsBDPCah_NvZf==eE9mp922j3eZJmVA@mail.gmail.com>
To: HCLS <public-semweb-lifesci@w3.org>
The next NCBO Webinar will be presented by Dr. Michael Kellen from Sage
Bionetworks on the "Sage Bionetworks Synapse Project" at 10:00am PT,
Wednesday, September 7.  Below is information on how to join the online
meeting via WebEx and accompanying teleconference. For the full schedule of
the NCBO Webinar presentations see:
http://www.bioontology.org/webinar-series.


ABSTRACT:
The recent exponential growth of biological “omics” data has occurred
concurrently with a decline in the number of New Molecular Entities approved
by the FDA, proving that biological research productivity does not scale
with biological data generation and the analysis and interpretation of
genomic data is a bottleneck in the development of new treatments. Sage
Bionetworks’ mission is to catalyze a cultural transition from the
traditional single lab, single-company, and single-therapy R&D paradigm to a
model with broad precompetitive collaboration on the analysis of large scale
data in medical sciences.  Part of Sage’s solution is Synapse, a platform
for open, reproducible data-driven science, which will support the
reusability of information facilitated by ontology-based services and
applications directed at scientific researchers and data curators. Sage
Bionetworks is actively pursuing the acquisition, curation, statistical
quality control, and hosting of datasets that integrate both clinical
phenotype and genomic data along with an intermediate molecular layer such
as gene expression or proteomic data.  We expect hosting these sorts of
unique, integrative, high value datasets in the public domain on Synapse
will seed a variety of analytical approaches to drive new treatments based
on better understanding of disease states and the biological effects of
existing drugs.  In this webinar, Dr. Michael Kellen, Director of Technology
at Sage Bionetworks will provide a demonstration of an alpha version of the
Synapse platform, and discuss its application to clinical science.


SPEAKER BIO:
Early in my career, I realized that the application of engineering
principles and methodology to the life sciences could improve the
productivity of research and bring important new treatments to patients.  At
Sage Bionetworks, I am working to bring support for large scale analysis of
biological networks and data into the public domain, and have overall
responsibility for the development of the Sage Commons platform to enable
large scale analysis of biological datasets via networks. In this role I
personally lead the gathering of product requirements, use cases, and
conceptual design of the platform.  I have recruited and manage a growing
team currently at 5 full-time software engineers supporting the development
of the Synapse system.

I have over 10 years experience developing software for academic and
corporate users in the life sciences, and have brought several innovative
and award-winning products to market in this space covering simulation, data
capture and analysis workflow, data integration, and team collaboration.
Prior to working at Sage Bionetworks, I held a variety of positions with
Teranode corporation since joining as the company's first employee in 2002,
covering product development, field consulting, product management, and
development management. I completed a doctorate in bioengineering at the
University of Washington in 2002 with a focus in computational biology.
Also at the UW, I helped develop scientific modeling and simulation
technology still in use in the open source community; a version of this
technology was subsequently licensed and commercialized by Teranode.


WEBEX DETAILS:
-------------------------------------------------------
To join the online meeting (Now from mobile devices!)
-------------------------------------------------------
1. Go to
https://stanford.webex.com/stanford/j.php?ED=107799137&UID=0&PW=NNjE3OWYzODk3&RT=MiM0
2. If requested, enter your name and email address.
3. If a password is required, enter the meeting password: ncbo
4. Click "Join".

-------------------------------------------------------
To join the audio conference only
-------------------------------------------------------
To receive a call back, provide your phone number when you join the meeting,
or call the number below and enter the access code.
Call-in toll number (US/Canada): 1-650-429-3300
Global call-in numbers:
https://stanford.webex.com/stanford/globalcallin.php?serviceType=MC&ED=107799137&tollFree=0

Access code:926 719 478



Trish Whetzel, PhD
Outreach Coordinator
The National Center for Biomedical Ontology
Ph: 650-721-2378
http://www.bioontology.org

Now on Twitter: http://twitter.com/#!/bioontology
and Facebook:
http://www.facebook.com/pages/National-Center-for-Biomedical-Ontology/127444774011153
Received on Tuesday, 6 September 2011 15:08:46 UTC

This archive was generated by hypermail 2.4.0 : Friday, 17 January 2020 17:21:00 UTC